atrial fibrillation

Findings from the Intermountain research were presented in a pair of studies at the American Heart Association's Scientific Sessions 2023, which is being held in Philadelphia. …

Fewer than 26% of Chinese Patients with Atrial Fibrillation are Prescribed an Anticoagulant, while in Japan Almost One-Third of Patients are Undertreated Approximately 63% of Cancer…

<!-- Name:DistributionId Value:8832724 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

The FDA has approved the first-ever vaccine for respiratory syncytial virus (RSV), the…

The researchers used the Hong Kong Clinical Data Analysis and Reporting System to identify all patients with a new diagnosis of atrial fibrillation between 2010 and 2018. Participants…

<!-- Name:DistributionId Value:8801805 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8800715 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

The FDA recently granted accelerated approval to pirtobrutinib (Jaypirca), a reversible Bruton's tyrosine…

FDA Fast-Track designation was granted to investigate abelacimab for the prevention of stroke and systemic embolism in patients with atrial fibrillation LILAC-TIMI 76 trial is the third…

"Our study focuses solely on high-risk TAVR patients with atrial fibrillation, which is a well-recognized surrogate of unfavorable prognosis," says lead investigator George Dangas, MD,…